LGND - Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M October, 18 2023 11:05 AM Ligand Pharmaceuticals Incorporated 2023-10-18 11:05:36 ET More on Ligand Pharmaceuticals, Ovid Therapeutics, etc. Ovid Therapeutics: The GABA Gambit In Seizure Wars Ligand: Nothing Exciting Stands Out For further details see: Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M